A generalist's guide to treating patients with depression with an emphasis on using side effects to tailor antidepressant therapy
- PMID: 20431115
- PMCID: PMC2878258
- DOI: 10.4065/mcp.2009.0565
A generalist's guide to treating patients with depression with an emphasis on using side effects to tailor antidepressant therapy
Abstract
This review provides a guide to the primary care physician for diagnosing and managing depression. To identify relevant articles, a PubMed search (ending date parameter, October 15, 2009) was conducted using the keywords depression, antidepressants, side effects, adverse effects, weight gain, sexual dysfunction, and sleep disturbance, and the reference lists of relevant articles were hand searched. This review explores the challenges in diagnosing depression that will and will not respond to antidepressants (ADs) and describes the value of 2-question screening instruments followed by in-depth questioning for positive screening results. It underscores the implications of veiled somatic presentations in which underlying depression is missed, leading to fruitless and expensive medical work-ups. Following this survey of the difficulties in diagnosing depression, the 4 options generalists have for treating a patient with depression are discussed: watchful waiting, antidepressant therapy, psychotherapy, and psychiatric referral. This review proposes that physicians, once they decide to prescribe, use AD side effects to advantage by selecting medications to minimize negative and maximize positive possibilities, thereby improving adherence. It focuses on the 3 most troubling adverse effects-sleep disturbance, sexual dysfunction, and weight gain. It provides AD-prescribing principles to assist primary care physicians in successfully managing depression and appropriately referring patients to a psychiatrist. Antidepressant therapy is not a panacea for treating patients with depression. An approach blending enlightened observation, medications, and psychotherapy often helps depressed patients recover to their former baselines.
Similar articles
-
[Diagnosis and therapy of depression in family practice].Orv Hetil. 2009 Sep 6;150(36):1684-93. doi: 10.1556/OH.2009.28675. Orv Hetil. 2009. PMID: 19709983 Review. Hungarian.
-
A practical approach to prescribing antidepressants.Cleve Clin J Med. 2013 Oct;80(10):625-31. doi: 10.3949/ccjm.80a.12133. Cleve Clin J Med. 2013. PMID: 24085807
-
Sexual dysfunction associated with major depressive disorder and antidepressant treatment.Expert Opin Drug Saf. 2014 Oct;13(10):1361-74. doi: 10.1517/14740338.2014.951324. Epub 2014 Aug 22. Expert Opin Drug Saf. 2014. PMID: 25148932 Review.
-
Depression.Prim Care. 1999 Jun;26(2):211-24. doi: 10.1016/s0095-4543(08)70003-4. Prim Care. 1999. PMID: 10318745 Review.
-
Impact of drug tolerability on the selection of antidepressant treatment in patients with major depressive disorder.CNS Spectr. 2009 Dec;14(12 Suppl 12):8-14. doi: 10.1017/s1092852900026353. CNS Spectr. 2009. PMID: 20397586 Review.
Cited by
-
Variations of depression treatment among women with hypertension.Health Care Women Int. 2015;36(6):730-50. doi: 10.1080/07399332.2015.1005303. Epub 2015 Jan 22. Health Care Women Int. 2015. PMID: 25611702 Free PMC article.
-
Depression-related innate immune genes and pan-cancer gene analysis and validation.Front Genet. 2025 Jan 10;15:1521238. doi: 10.3389/fgene.2024.1521238. eCollection 2024. Front Genet. 2025. PMID: 39867577 Free PMC article.
-
Exploring Symptom Clusters in Chinese Patients with Diabetic Kidney Disease: A Network Analysis.Int J Gen Med. 2024 Mar 7;17:871-884. doi: 10.2147/IJGM.S447921. eCollection 2024. Int J Gen Med. 2024. PMID: 38468820 Free PMC article.
-
Antidepressant-like Effect of 3-n-Butylphthalide in Rats Exposed to Chronic Unpredictable Mild Stress: Modulation of Brain-Derived Neurotrophic Factor Level and mTOR Activation in Cortex.Neurochem Res. 2021 Nov;46(11):3075-3084. doi: 10.1007/s11064-021-03397-9. Epub 2021 Aug 10. Neurochem Res. 2021. PMID: 34374900
-
Antidepressant-like Effects of LPM580153, A Novel Potent Triple Reuptake Inhibitor.Sci Rep. 2016 Apr 7;6:24233. doi: 10.1038/srep24233. Sci Rep. 2016. PMID: 27052887 Free PMC article.
References
-
- Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289(23):3095-3105 - PubMed
-
- Nichols GA, Brown JB. Following depression in primary care: do family practice physicians ask about depression at different rates than internal medicine physicians? Arch Fam Med. 2000;9(5):478-482 - PubMed
-
- Dietrich AJ, Oxman TE, Williams JW., Jr Treatment of depression by mental health specialists and primary care physicians [letter]. JAMA 2003;290(15):1991 - PubMed
-
- Belmaker RH, Agam G. Major depressive disorder. N Engl J Med. 2008;358(1):55-68 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical